Novo Nordisk considers direct US listing for Ozempic stock

CEO Mike Doustdar highlights the benefits of a direct listing for US investors.

Published 3h1 sourceNotable

≈ 18sSpeed

The fact

This move could ease American shareholders' access to the Danish stock.

Novo Nordisk leads the global market for diabetes and obesity treatments.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on September 23, 2026